Evaluation of Diabetes Mellitus, Hyperlipidemia, and Thyroid Disease Comorbidities in Palmoplantar Pustulosis. [PDF]
Akbaş A +3 more
europepmc +1 more source
Successful Treatment of Refractory Palmoplantar Pustulosis With Bimekizumab in a Patient With Multiple Sclerosis: A Case Report. [PDF]
Mahboob O +4 more
europepmc +1 more source
Tofacitinib for the treatment of palmoplantar pustulosis: A multicenter prospective study. [PDF]
Tao Y +10 more
europepmc +1 more source
Approach to Palmoplantar Pustulosis
Defne Özkoca, Tuğba Kevser Uzunçakmak
openaire +1 more source
From apremilast to JAK inhibitors-salvage treatment strategies for refractory palmoplantar pustulosis: case series. [PDF]
Pan Y +7 more
europepmc +1 more source
Efficacy and Safety of Tofacitinib in Palmoplantar Pustulosis: A Retrospective Study. [PDF]
Lyu S, Xue X, Wang N, Liu H, Zhang F.
europepmc +1 more source
Targeting the JAK/STAT pathway in palmoplantar pustulosis: a review. [PDF]
Vimbai Chirindo C +4 more
europepmc +1 more source
Relapsing Polychondritis With Palmoplantar Pustulosis: A Case Report. [PDF]
Vasileios L, Olga K, Panayiotis VG.
europepmc +1 more source
Danyang Fan, Fuqiu Li, Zhe Liu, Zhanhan Tang, Sha Lv Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, 130000, People’s Republic of ChinaCorrespondence: Sha Lv, Department of Dermatology, The second hospital of Jilin ...
Fan D, Li F, Liu Z, Tang Z, Lv S
doaj
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial. [PDF]
Terui T +16 more
europepmc +1 more source

